Novo Nordisk GLP-1 liraglutide may slow Alzheimer’s progression

  Health Trends, Health Trends - USA

A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.

George Frey | Reuters

An older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer’s disease by…



Source link